Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.
| Autor: | Lang JE; University of Southern California Department of Surgery, Division of Breast and Soft Tissue Surgery, Norris Comprehensive Cancer Center, Los Angeles, California., Wecsler JS, Press MF, Tripathy D |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of surgical oncology [J Surg Oncol] 2015 Jan; Vol. 111 (1), pp. 81-90. Date of Electronic Publication: 2014 Aug 05. |
| DOI: | 10.1002/jso.23732 |
| Abstrakt: | Precision medicine involves understanding the molecular drivers unique to an individual patient's cancer so that specific factors may be targeted with the goal of improved patient outcomes. The purpose of this article is to review standard of care and research grade (non-standard of care) biomarkers in breast cancer that may be useful for diagnosis, prognosis and targeted therapy. (© 2014 Wiley Periodicals, Inc.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text